Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,533 | -24,468 | -13,150 | -5,514 | -8,280 |
| Depreciation Amortization | 52 | -56 | -112 | -146 | -66 |
| Other Working Capital | 1,396 | 1,236 | -614 | 1,316 | -811 |
| Other Operating Activity | 4,708 | 3,138 | 1,890 | 647 | 488 |
| Operating Cash Flow | $-29,377 | $-20,150 | $-11,986 | $-3,697 | $-8,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -52,106 | -2,401 | 1,673 | 23,061 | -33,485 |
| PPE Investments | -1,538 | -1,184 | -216 | -33 | -76 |
| Investing Cash Flow | $-53,644 | $-3,585 | $1,457 | $23,028 | $-33,561 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 200 |
| Common Stock Issued | 254,499 | 254,306 | 254,276 | 254,271 | 1 |
| Other Financing Activity | 124,712 | 124,712 | 124,712 | 124,712 | 44,331 |
| Financing Cash Flow | $379,211 | $379,018 | $378,988 | $378,983 | $44,532 |
| Beginning Cash Position | 2,379 | 2,379 | 2,379 | 2,379 | 77 |
| End Cash Position | 298,569 | 357,662 | 370,838 | 400,693 | 2,379 |
| Net Cash Flow | $296,190 | $355,283 | $368,459 | $398,314 | $2,302 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,377 | -20,150 | -11,986 | -3,697 | -8,669 |
| Capital Expenditure | -1,538 | -1,184 | -216 | -33 | -76 |
| Free Cash Flow | -30,915 | -21,334 | -12,202 | -3,730 | -8,745 |